Andreas Suchanek

Laboperator connects science through the unification of instruments, data, and teams to create efficient, compliant, and scalable laboratories. Our platform enables laboratories to operate smarter — connecting devices, automating workflows, and ensuring complete data integrity across the entire lab ecosystem. Designed to meet the needs of both non-regulated and regulated settings, Laboperator empowers organizations to increase efficiency, maintain compliance, and seamlessly scale from single labs to global operations. By transforming disconnected systems into one digital backbone, Laboperator bridges the gap between R&D and manufacturing — accelerating innovation from bench to batch. Laboperator GmbH continues its commitment to delivering trusted laboratory execution and connectivity solutions — now backed by Xavo R&D, a global leader in laboratory and manufacturing digitalization.

The analysis of large health data sets has the potential to advance patient-centered care significantly. It can also be used to manage the regulatory requirements for medical technology and pharmaceuticals in the area of clinical studies and trials more efficiently. As a driver of innovation in the fields of AI and medical data management, we are focused on the digitalization, utilization and data-based automation of processes in the health care sector.

Welcome to Semalytix! Semalytix, the trailblazer in AI-driven innovations, empowers pharmaceutical companies to embrace a patient-centric approach like never before. With their revolutionary Pharos platform, fuelled by state-of-the-art AI and LLM technology, Semalytix undertakes the colossal task of consuming and analysing millions of forum posts, social media discussions, and CRM system records in the blink of an eye. Pharos becomes the conduit for capturing and harnessing the pulse of real-world perceptions and experiences shared by both healthcare practitioners and patients in the here and now. Through its captivating living reports, Pharos bestows invaluable insights upon pharmaceutical giants, guiding them to laser-focus on their customers genuine needs. It unlocks the profound understanding of what truly holds the potential to enhance their well-being, transforming lives in ways previously unimagined. Founded in 2015, Semalytix has grown to a team size of 75 employees and has executed more than 40 projects with the pharmaceutical industry with a total volume of EUR 3.8M between 2015 – 2019.

Laboperator connects science through the unification of instruments, data, and teams to create efficient, compliant, and scalable laboratories. Our platform enables laboratories to operate smarter — connecting devices, automating workflows, and ensuring complete data integrity across the entire lab ecosystem. Designed to meet the needs of both non-regulated and regulated settings, Laboperator empowers organizations to increase efficiency, maintain compliance, and seamlessly scale from single labs to global operations. By transforming disconnected systems into one digital backbone, Laboperator bridges the gap between R&D and manufacturing — accelerating innovation from bench to batch. Laboperator GmbH continues its commitment to delivering trusted laboratory execution and connectivity solutions — now backed by Xavo R&D, a global leader in laboratory and manufacturing digitalization.

The analysis of large health data sets has the potential to advance patient-centered care significantly. It can also be used to manage the regulatory requirements for medical technology and pharmaceuticals in the area of clinical studies and trials more efficiently. As a driver of innovation in the fields of AI and medical data management, we are focused on the digitalization, utilization and data-based automation of processes in the health care sector.

Xavo is a software company with a sole focus on delivering exceptional value to Biopharma R&D through Software-as-a-Service. Xavo has reimagined how to address the strategic problem in the Biopharma R&D Sample Management realm which is to optimally fulfill changing demand for assays and materials based on available finite lab capacity and material inventory. With its SaaS product, Xavo R3, it helps Sample Management groups to consistently deliver the right material in the right format to the right recipient in the right quality to promise on time every time by providing the best combination means.

Welcome to Semalytix! Semalytix, the trailblazer in AI-driven innovations, empowers pharmaceutical companies to embrace a patient-centric approach like never before. With their revolutionary Pharos platform, fuelled by state-of-the-art AI and LLM technology, Semalytix undertakes the colossal task of consuming and analysing millions of forum posts, social media discussions, and CRM system records in the blink of an eye. Pharos becomes the conduit for capturing and harnessing the pulse of real-world perceptions and experiences shared by both healthcare practitioners and patients in the here and now. Through its captivating living reports, Pharos bestows invaluable insights upon pharmaceutical giants, guiding them to laser-focus on their customers genuine needs. It unlocks the profound understanding of what truly holds the potential to enhance their well-being, transforming lives in ways previously unimagined. Founded in 2015, Semalytix has grown to a team size of 75 employees and has executed more than 40 projects with the pharmaceutical industry with a total volume of EUR 3.8M between 2015 – 2019.

arivis is a specialized biomedical big image data and compliance software company in the life science industry. Its revolutionary, award winning software enables users to visualize, analyze, distribute and to manage even multi-terabyte multi-dimensional (2D, 3D, 4D, 5D, 6D) image datasets that are e.g. created by microscopes or scanners, very fast, efficient – and on ordinary PCs and laptops! Moreover arivis solutions help customers to meet the world-wide ever-increasing regulatory, quality and compliance requirements in research, clinical trials, approval, and maintenance of medical devices and medicinal products. arivis products are used by small and medium sized biotech companies as well as by the world’s leading medical device and pharmaceutical companies and by international renowned research associations, organizations and universities. Headquartered in Munich, arivis is an international fast growing company that already generates more than 50% of its turnover in more than 25 countries outside of Germany. Especially in the USA arivis has built up a broad customer base and expects exponential further growth. Besides the US West Coast headquartered subsidiary in Phoenix, (AZ), arivis will open a further US-office in Washington, D.C. in September. That will ensure customers an even better support than at present.